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We investigated the HLA-C locus of 87 unrelated 
patients with chronic plaque psoriasis by genotyping 
with sequence-specifc amplification primers. The 
HLA-Cw*0602 allele was significantly increased in 
male and female type I psoriatics but not significantly 
increased in either male or female type II psoriatics. 
The overall frequency of Ala-73 (present in Cw*04, 
Cw*0602, Cw*07, Cw*12, Cw*1503, and Cw*17) in 
psoriatics was 88.5% but the incidence of Ala-73 in 
our Caucasian controls was also high at 84.3%. Ala-73 
was present in 97.2% of type I and 85.7% of type II 
male psoriatics (X2 = 8.43, p = 0.001; ~ = 0.01, p = 
nonsignificant, respectively), in contrast to 81.5% of 
type I and 80% of type II female psoriatics (nonsig-
nificant). HLA-Cw*0602 appeared more discriminat-
ing in determining disease susceptibility in our pop-
ulation than Ala-73, in line with earlier serologic 
studies implicating HLA-Cw6. Thus, although the 
I t is well recognized by standard serologic typing that psoriasis_ is significantly associated with the human leuko-cyte antigens (l-ILA) Al, B13, B17, B37, B39, Cw *0602, Cw11, and DR7 (Tsuji el a/, 1977; Bretmer ef al, 1978; Murray et al, 1980; Tiilikainen et a/, 1980; Marcussen el al, 
1981; Ozawa et al, 1981), but psoriasis is unique because of its 
association with certain HLA-C loci. Tight linkage between 
HLA-C loci and psoriasis has been demonstrated by analysis of 
restriction fragment length polymorphisms and pulsed-field gel 
electrophoresis (Ozawa et al, 1988). HLA-Cw*0602 is the most 
frequently described association and has been confirmed in other 
racial groups (Ozawa eta/, 1988; Ikiiheimo eta/, 1994; Roitberg-
Tambur et a/, 1994) . T l:lls indicates that there is tight linkage 
between the HLA- C loci and the gene controlling susceptibility to 
psoriasis or that amino acid residues on certain HLA- C locus 
products may themselves directly contribute to disease susceptibil-
ity. An association between a specific nucleotide sequence of 
HLA-C (A.la-73) has been shown to be strongly associated with 
psoriasis vulgaris in ] a pan (Asahina et a/, 1992). The nucleotide 
Manuscript received November 5, 1996; revised April 22, 1997; accepted 
for publication May 7, 1997. 
Reprint requests to: Dr. Eleanor Mallon, Department of D ermatology, 
Chelsea and Westminster Hospital, 369 Full1am Road, London SW10 
9NH, U.K. 
Abbreviations: MHC, major histocompatibility complex; SSP, sequence-
specific primers . 
frequency ofHLA-Cw*0602 decreased from 54.0% in 
type I to 29.2% in type II psoriatics, the overall 
frequency of Ala-73, present in 90.4% of type I and 
83.3% of type II psoriatics, did not. (i) Thus this study 
confirms the strong association between psoriasis and 
HLA-Cw*0602 by using sequence-specific amplifica-
tion primers. (ii) Results show that Ala-73 on HLA-C 
molecules is increased in frequency in psoriasis, but 
results observed show an association more subtle 
than previously thought, with HLA-Cw*0602 playing 
the major role. (iii) This report documents the 
differential association of HLA genes in male and 
female psoriatic patients. An interaction between 
gender and immunogenetics may influence suscep-
tibility to psoriasis. Ke]' wot'ds: Iutman lenkoc]'te anti-
gens/ sequence-specific amplifica.tion pvimet'slgeudev/imm 11-
nogenetics. J Invest DemJatol 109:183-186, 1997 
sequence coding for alanine at pos!tlon 73 was significantly in-
creased in Japanese patients with psoriasis compared with healthy 
individuals (81 vs . 48%,; p < 0.0001). Codon 73, wl:llch codes for 
Ala- 73 instead of Thr- 73, is an important component of HLA-C 
genes and is present in Cw*04, Cw *0602, Cw*07, Cw*12, 
Cw*1503, and Cw*17 alleles . This amino acid is situated on the al 
domain of the HLA-C molecule, which forms one side of the 
putative antigen binding cleft (Bjorkman et a/, 1987). The residue 
may play an important role in determining susceptibility to tl1e 
disease, perhaps through determining the confonnation of the C 
cleft and subsequently the peptide that binds to it. 
We have investigated the HLA-C locus in a group of 87 
unrelated Caucasian patients with chronic plaque pso1iasis to 
determine whether A.la- 73 is a disease susceptibility factor in a 
United Kingdom populati.on. Complement- mediated microcyte-
toxicity (serology) using human alloantiserum is the most widely 
used method of typing for the HLA class I products HLA-A, 
HLA-B, and HLA- C. Although HLA-A and HLA-B serology is 
reasonably accurate and reliable, serologic detection of HLA-C is 
poor, up to 50% of the population having only one detectable 
HLA-C allele (Baur et a/, 1984; Aizawa et al, 1986), and many 
l-ILA-C alleles are not detected at all by serology (Bunce et -a/, 
1994b). Recently, typing by polymerase chain reaction (PCR) 
using either sequence-specific primers (PCR-SSP; Bunce et a/, 
1994a, 1994b) or sequence-specific probes (Levine et a/, 1994; 
Kennedy et al, 1995) has proved to be accurate and efficient in 
detecting HLA-C. To elucidate the role ofHLA-C in psoriasis, we 
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used h igh-resolu tion PCR-SSP (Bunce et a/, 1996) supplemented 
with an additional PCR specificall y to detect Ala-73 . 
MATERIALS AND METHODS 
P atients and Controls Eighty-seven unrelated Caucasian patients (50 
male and 3 7 female) with chronic stable plaque psoriasis were recruited 
randomly from the dermatology o utpatient clinic. T he overall age range 
was 13-81 y and the mean age of the group was 52 y. T he peak age of onset 
in the male patients was 25- 29 y (24.5% of male population) with a further 
peak at 60-64 y (1 0.2% of male popula tion) . Females bad an earlier peak 
age of onset at 15-1 9 y (18.4% of female population) and a further peak at 
60 - 64 y (13.2% of female population). There were 36 male (72'Yo) and 27 
fema l.e patients (73%) with early-onset di sease (onset less than 40 y old) , and 
these were grouped to type J psoriasis; 14 male and 1 0 female patients with 
late-onset disease (onset greater than 40 y old) were grouped to type II 
psoriasis. Typing was also performed on a control population of 604 random 
Caucas ian cadaver donors composed of 366 m ales and 238 femal es (Bunce 
el a/, 1996). 
DNA Extraction Genomic DNA was isolated from l ymphocytes ob-
tained from ethylenediamine tetraacctic acid anti-coagula ted blood. The 
DNA was prepared by an improved salting-out method (Bunce el a/, 1995). 
Briefly, the buffy coat from 5 ml of anti-coagulated blood was lysed in a red 
cell lysis buffer consisting of0.144 M NH 4 Cl and 1 mM NaHC03 . After 
centrifugation, the peliet was rinsed in red cell lysis buffer and resuspended 
in 3 ml of nuclei lysis buffer (0.4 M NaCl, 2 mM sodium ethylenediamine 
tetraacetic acid, 10 mM Tris-HCl) and 200 [.Ll of 10% (wt/vol) sodium 
dodecyl sulfate in water. One hundred twenty microliters of 10 mg 
proteinase K per ml in PK buffer (1.5 mM sodium ethylenediamine 
tetraacetic acid , 1% sodium dodecyl sul fate, pH 8.2) were added, and the 
lysate was incubated for 12 h at 42°C with overhead rotation. After 
incubation, 1 mJ of 6 M NaCI and 3 mJ of c hloroform were added, 
vortex-mixed, and centrifuged at 3000 rpm for 30 min . DNA aspirated from 
the top aqueous phase was precipitated with 95% ethanol, washed in 70% 
ethanol, and resuspended in di stil led water. 
Amplification Primers and PCR Conditions Amplification primers 
and primer mixes were as previously described (Bunce et a/, 1996). Ala-73 
was specifically detected with a combination of sense primer 5'-ACAA-
GCGCCAGGCACAGG(HLA-C exon 2, 199-216) and the anti-seme 
primer 5'-GCGGCG(G/T)TCCAGGAGCG (HLA-C exon 3, 120 -136), 
which produced a 447-bp ampl.icon when Ala-73 was present in an HLA-C 
locus allele . Amplification control primers giving rise to a 796-bp fragment 
fi:om the third in tron of J:ILA-DRB1 were included in all PCR s as 
previously described (Olerup et a/, 1992). I>CR conditions and parameters 
were as previously described (Bunce el. a/ , 1995) , except for the addition of 
creosol red (62 mg per ml) in the prin1er mixes as an aid to dispensing. Gel 
electrophoresis conditions were as previously described (Bunce e/ a/, 1995). 
T he J>CR-SSI> HLA- C typing has been shown to be highly re liab le in our 
laborato ry (Bunce et a/, l994a, l994b, 1995, 1996) and in other laboratories 
(Ando et a/, 1996). Furthermore, PCR-SSP HLA-C typing oflnternational 
Histocompatibili ty Workshop Cell Lines (Yang el. a/, 1987) is comparable to 
results obtained with PCR-sequence- specific probes l-ILA-C typing (Levine 
e/ a/, 1994; Kennedy e/ a/ , 1995; Prasad eta/, 1996). 
Analysis Antigen fre quencies were calculated by antigen counting and 
gene frequencies were calculated by using the formula: gene frequency = 
1 - (l - antigen frequency) 112• 
Significance was calculated with J! test with Yate's correction (Bradford 
Hill and Hill , 1991). T he p values were corrected by multiplying by the 
number of antigens investigated. 
RESULTS 
The genotpye and antigen freq uen cies identified by PCR- SSP in 
the 604 controls and 87 patie n ts with chronic plaque psoriasis are 
shown in Table I, and the significance of HLA-Cw *0602 and 
A la-73 ar e sh own in Table II. Some Cw alleles are not represented 
in the tested Caucasian population (Table I) and are thought to be 
eith er the result of sequen ce errors or found only rarely (if at all) in 
Caucasian populations (Bunce et al, 1996) . 
There was a strong associa tion b etween chronic plaque psoriasis 
and HLA-Cw *0602. HLA-Cw*0602 was present in 54.0% of type 
I psoriatics (X2 = 23.05; p < 0.0001) and was significantly increased 
in both male 55.6% (X2 = 25.14; p < 0 .0001) and female type I 
psoriatics 51.8% (X2 = 20 .32; p < 0.0001). In contrast, HLA-
Cw*0602 was present overall in only 29.2'Yo of type II p soriatics, 
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Table I. PCR- SSP-Determined Genotype and Antigen 
Frequencies in Controls and Psoriatics" 
Random Caucasians Psoriatics 
(n = 604) (n = 87) 
Geno type Antigen Genotype Antigen 
Allele Frequency Frequency Frequency Frequency X''' p value 
Cw*0102 0.028 5.464 0.023 4.598 0 ns 
Cw*0202 0.029 5.629 0.053 10.345 0.94 < 0.5 
Cw*0302 
Cw*0303 0.046 8.940 0.023 4.598 0.88 < 0.5 
Cw*0304 0.085 16.225 0.065 12.644 0.27 ns 
C w *0401 0.1.00 19.040 0.103 19.540 0.01 ns 
C w*0402 
Cw*0403 
Cw*0501 0.104 19.702 0.090 17.241 0.07 n s 
C w *0602 0.107 20.199 0.273 47. 126 15.04 < 0.0001 
Cw*0701 0.165 30.298 0.129 24.138 0.67 < 0.5 
Cw*0702 0.150 27.980 0.103 19.540 1.53 < 0.5 
Cw*0703 
Cw*0704 0.019 3.974 0.012 2.299 0.08 ns 
C w*0801 
Cw*0802 0.038 7.450 0.012 2.299 1.87 ns 
Cw*0803 
Cw*1202 0.004 0.828 0.012 2.299 0.07 ns 
Cw*1203 0.032 6.457 0.041 8.046 0.03 n s 
Cw* 1301 
Cw* 1402 0.011 2.152 0.63 < 0.5 
Cw*1403 
Cw*1502 0.021 4.139 0.01 7 3.448 0.01 ns 
Cw*1503 
Cw* 1504 
Cw*1505 0.002 0.33 1 1.32 < 0.5 
Cw*1601 0.041 8.113 0.035 6.897 0 ns 
Cw*1602 0.002 0.331 1.32 < 0.5 
Cw*1701 0.004 0.828 0.04 ns 
Cw*l801 
"Genotype and antige n frequencies identified by PCR- SS P in 604 random U.K. 
C aucasians and 87 psoriasis patients. 
11 ;?- between contro l and psoriatics :m tigen frequencies calculated by using Yates 
correction . 
male psoriatics m ade up 28 .6%, and female psoriatics m ade up 30% 
(not significant). 
Of the controls , 306 of 366 maJes (83.6%) were Ala-73 -positive 
comp are d with 203 of 238 females (85.3%; nonsignifi can t) . The 
overall frequency of Ala-73 in psoriatics was 88.5% compared wi th 
84.3% in the control group . Ala- 73, however, was p resent in 97 .2'!/o 
(35 of36) of type I an d 8 5.7"1<• (12 of14) of type II male psoriatics (K = 8.43 and p < 0.001 11s . .(1 = 0.01 and p = not significant) , 
in contr ast to 81.5% (22 of27) of type I and 80% (8 of10) of type 
ll female p soriatics (not significant). 
Thus although the HLA- Cw*0602 frequency decreased from 
54.0% in type I psoriatics to 29.2% in type ll psoriatics, the overall 
fi·equency of Ala-73 did not. 
DISCUSSION 
C urrent eviden ce indicates there is tight linkage b e tween l-ILA-C 
loci and the gen e(s) controlling susceptibility to psoriasis. Psoriasis 
is associate d with an increased frequency ofHLA Cw6 (Cw*0602), 
assigned a re la tive risk of 14 - 24 in various rep o r ts (Elder et al, 
1994). Tins association is mlique, as no other disease is known to be 
primarily linked to the HLA- C loc us but the association m ay simply 
b e the result of linkage disequilibrium with other putative disease 
susceptibility genes. 
Two types of p soriasis can be diiferentiate d according to the age 
of onset (He nseler and Christopher, 1985) . Type I manifests early 
in life, is HLA-Cw*0602-associated, and frequently affects other 
family m e1nbers. Type II manifests later in life and is more like ly to 
be sporadic and nonf.1 milial. FemaJes are re ported to develo p 
psoriasis at an earlier age than males (Holgate, 1975; Henseler and 
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Table II. HLA-Cw*0602 Is Significantly Increased in Male and Female Type I Psoriatics and Alanine at Position 73 Is 
Significantly Increased in Male Type I Psoriatics Only 
Subject 
AU type I psoriatics (n = 63) 
Female t)'pe I psoriatics (n = 27) 
Male type I pso ri atics (n = 3P) 
All type II psoria tics (n = 24) 
Female type II psoriatics (n = 1 0) 
Male type II psoriatics (n = 14) 
All psori atics (type I and 11 ) 



















Christopher, 1985) . This was the case in ou r cohort of patients , 
fema les with a peak age of onset at 15-1 9 y in contrast to males with 
a peak age of onset at 25-29 y. 
In this study, HLA-C locus genotyping was performed with 
seq uence- specific amplification primers. Complement-mediated 
microcytotoxicity (serology) using human alloantiserum is the most 
wide ly used method for typing the classical transplantation anti-
gens, including I-ILA-C loci . Serology is ineffective for HLA-C 
typing (Bunce el a/, 1996), however, possibly due to the fact that 
despite similar mRNA levels , HLA-C antigens are expressed on cell 
surf.1ces at approximately 10% of the level of either HLA-A or 
HLA-B (Gussow el a/, 1987) . This may be caused by inefficient 
assembly ofHLA-C molecules with {32-microglobulin (Neefjes and 
Ploegh , 1988) or rapid turnover of HLA-C mRN A (McCutcheson 
et a/, 1995) , or it is possible that haplotype-specific defects and 
diffe rences in the regula tory complexes of HLA-C may cause 
differential expression of l-ILA-C (Cereb el a/, 1994). The lack of 
efficient L-1 LA-C cell-surface expression coupled with a relative lack 
of HLA-C serologic typiJlg reagents resu lts in a 3 7.2°/., discrepency 
rate between serology and PCR-SSP in United Kingdom Cauca-
sians (13unce el a/, 1996). To accurately identifY serologically 
detectabl e and undetectable l-ILA-C antigens, we used a PCR-SSP 
system to detect all the sequen ced HLA-C ;tll eles (Bunce et a/ , 
"1996) and to independently detect Ala-73 . 
The analysis of l-ILA-C PCR-SSP typing from 87 unrelated 
patients and 604 normal controls has shown a strong association 
between psoriasis and HLA-Cw *0602. HLA-Cw *0602 was signif-
ica ntly increased in type r psOJ:ias is in bo th male and fema le patients. 
In contra st the presence of HLA-Cw*0602 in type ll psoriatics did 
not reach statistica l significance. There was a h.igh fi·equency of 
Ala-73 in all psoriatics (88.5 %), confirming the l1igh incidence 
previo usly reported in Japan . Ala-73 was also present at high 
freq uency in th e general Caucasian popu lation (84.3 %), and there 
was no signifi cant difference in Ala-73 in mal e and female controls. 
Ala-73 was carried by 97.2% of type I male psoriatics compared 
with 85 .7% of type ll male psoriatics (X2 = 8.43, p = 0.001), 
whereas Ala-73 was canied by only 81.5% of type I female 
psoriatics and 80'Yo of type II female psoriatics, showing no signif-
icant difference compared to the control population. Since type 1 
disease develops earlier in young females and appears more strongly 
linked to the major histocompatibility complex (MHC), one might 
expect femal e patients to have a stronger MHC association. T lus is 
not so, but our results suggest there is an interplay betwee.n gender 
and the MHC in susceptibility to psoriasis . Further, tlus study 
confirms the i1~1portance of Ala- 73 on l-ILA-C molecules as a 
susceptibility factor to the development of psoriasis but suggests 
that the association is more subtl e than previously tliought, with 
HLA-Cw *0602 playing the major role. . 
A considerable proportion of the ceilular infiltrate Ul psoriasis 
consists of activated T helper cells. A popular hypothesis is that 
inflammation and hyperproliferation in psoriatic lesions is the result 
of release of mediators fi·om lymphocytes and associated cells 
during a cell-mediated immune response induced by the local 
















Alanine at Position 73 
K- p value 
us < 0.5 
0.51 Not significant 
8.43 < 0.001 
0.15 Not significant 
0.96 Not significant 
0.01 Not significa nt 
presentation of as yet mudentified antigen(s) (Camp, 1992). The 
responses to such local antigens may be the result of cross-reactivity 
with foreign antigens such as streptococca.l or retrovi.ral proteins 
(Bos, 1988). l-ILA molecules bind to antigens, and the l-ILA-peptide 
complex is recognized by T lymphocytes, which become activated 
and initiate an immune response to tha t antigen. It is conceivable 
that certain HLA molecules act as susceptibility factors to psoriasis 
through the interaction between l-ILA molecules and local antigens, 
leading to an autoilnmune response. Microorganisn1s may serve as 
triggering agents through molecular mimicry. Analysis of protein 
and DNA databases has revealed that the sigma 2 protein of type 1 
reovirus contau1s an ami11o acid sequence, Gln-Ala-Gln-Aia-Asp-
Arg-Val, wluch is identical to the disease susceptibility determinant 
of the HLA-C molecuJe (George ct al, 1987; Asahi.na et a/, 1992). 
Crystailographic analysis ofHLA class I molecules has revealed that 
these molecules have a receptor-like shape with a peptide binding 
groove (Bjorkman eta/, 1987; Garrett el al , 1989) . Alteration in the 
atnino acid composition of the groove would cause dintensional or 
polarity changes, leading to differential ability of the HLA molecule 
to bind and present antigens. 
To e lu cidate whether Ala-73 or any other HLA-C amino acid is 
involved in susceptibility to psmiasis , it would be necessary to 
identifY tt·iggel"ing agents and analyze T-cell clones that recognize 
the HLA-C molecule-antigen complex. Another potential mecha-
nism re la tes to a gene designated S that has recently been identified 
in the class I region of the MHC and is expressed exclusively in 
terminally differentiated keratinocytes (Zhou and Chaplin, 1993 ). 
T he gene is closely linked to the l-ILA-C gene, located 160 kb 
telomeric, and reported to be found in association with HLA-C 
loci. Although the func tion of the S protein is unknown , the 
restriction of its expression to the granular cell layer of the 
epidermis suggests that it participates in establishing the unique 
structure of terminally differentiated skin. One could speculate that 
certain alleles of the S gene may contribute to the pathogenesis of 
psotiasis, and tl1ese genes are in linkage disequilibrium with certain 
HLA-C loci. 
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